Amphastar Pharmaceuticals
AMPH
AMPH
222 hedge funds and large institutions have $1.06B invested in Amphastar Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 90 increasing their positions, 74 reducing their positions, and 14 closing their positions.
Holders
222
Holders Change
+19
Holders Change %
+9.36%
% of All Funds
3.75%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
37
Increased
90
Reduced
74
Closed
14
Calls
$6.06M
Puts
$60.7M
Net Calls
-$54.6M
Net Calls Change
-$19.7M
Top Buyers
| 1 |
PCM
1
Portolan Capital Management
Boston,
Massachusetts
|
$9.56M |
| 2 |
2
Morgan Stanley
New York
|
$28.8M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$53.6M |
| 4 |
4
Goldman Sachs
New York
|
$11.5M |
| 5 |
CM
5
Castleark Management
Chicago,
Illinois
|
$6.7M |
